3/23, 8:16 AM (Source: TeleTrader)
more TeleTrader news

Roche: Antibody cocktail 70% effective in preventing COVID deaths

F. Hoffmann-La Roche AG announced on Tuesday that its antibody cocktail of casirivimab and imdevimab has proven to be 70% effective in preventing risks of hospitalization or death by 70% for people infected with the coronavirus.

The phase 3 trial also showed that the cocktail has "the ability to reduce symptom duration from 14 to 10 days," the company noted.

"New infections continue to rise globally with over three million reported cases last week, so this investigational antibody cocktail may offer hope as a potential new therapy to high-risk patients - particularly in light of recent evidence showing that casirivimab and imdevimab together retain activity against key emerging variants," Roche's Chief Medical Officer Levi Garraway said in a statement.

Breaking the News / GA